跳至主要内容
临床试验/PACTR202402715350374
PACTR202402715350374尚未招募Unknown

Reduction of Septic Complications in High-Risk Compound Skull Fractures

one0 个研究点目标入组 116 人开始时间: 2024年2月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
one
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • All adults (age 18 and above) presenting with compound skull vault fractures who have:
  • 1. Received primary wound care within 12 hours of injury.
  • 2. Receive definitive surgery within 72 hours of injury.
  • 3. Received a single dose of 2g Cefazolin intravenously within 12 hours of injury and have any one of the following risk factors for septic complications:
  • - air sinus involvement
  • - or clinical or radiological evidence of wound contamination

排除标准

  • Children under the age of 18.
  • Gunshot injuries.
  • Septic complication at time of presentation.
  • Compound skull fractures with no high-risk features.
  • Patients suffering from base of skull fractures only.
  • Closed skull fractures.
  • Known antibiotic allergy.
  • Patients known with severe comorbidities such as end stage renal disease, heart failure, liver failure.

研究者

发起方
one

相似试验